The 2023 annual meeting of the World Health Organization (WHO) Clinical Consortium on Healthy Ageing (CCHA) took place in Geneva, Switzerland in December 2023. It was the group’s ninth gathering. The meeting consisted of seven panels of presentation and discussion taking place across three days: 1.WHO’s new initiatives on ageing and health 2.Musculoskeletal health 3.Implementation of the ICOPE approach 4.Emerging themes to strengthen integrated care 5.Updating ICOPE care pathways 6.Multidimensional approach to research on healthy ageing 7.CCHA and GNLTC joint panel: Continuum of integrated care for older people

The 2020 annual meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the sixth gathering of an international group of clinical leaders, drawn from the full breadth of the field of ageing to progress the work agreed by Member States under the 2016 WHO Global Strategy and Action Plan on Ageing and Health and the UN Decade of Healthy Ageing (2021-2030). This meeting report summarizes the discussion and provide the opportunities for potential future action to advance two action areas of the Decade: Integrated care and Long-term care.

“Alzheimer’s Disease: From Molecular Mechanisms to Clinical Practices” explores the extensive perspective from the molecular foundations to the clinical diagnosis and treatment of Alzheimer’s disease. The book serves as a fundamental resource for understanding the neurobiological basis and molecular pathogenesis of Alzheimer’s, while also discussing the challenges and opportunities of transitioning from the laboratory to clinical settings. The initial sections of the book comprehensively examine the fundamental molecular characteristics of Alzheimer’s disease; these include the accumulation of amyloid-beta peptide, hyperphosphorylation of tau protein, and how these processes lead to synaptic dysfunction and neuronal death. These chapters provide strategies on how to understand the pathology of the disease at a molecular level and how this knowledge can be translated into clinical practice. Subsequent parts focus on the development and use of biomarkers for the early diagnosis of Alzheimer’s disease. In addition to the role of genetic predispositions, the effects of environmental factors and lifestyle choices on Alzheimer’s disease are discussed, highlighting the multifactorial nature of the disease. In conclusion, this book is a valuable resource for clinicians, researchers, and medical students specializing in the field. It provides essential scientific and practical information necessary for a better understanding and management of Alzheimer’s disease, offering a comprehensive perspective on the integration of molecular mechanisms with clinical applications.

This book, Design for Sustainable Inclusion, was inspired and informed by the United Nations Sustainable Development Goals. These include, among others, ‘good health and well-being’, ‘reduced inequalities’ and ‘sustainable cities and communities’. Addressing this challenge requires a cross-disciplinary approach and close collaboration with many stakeholders. The Cambridge Workshop on Universal Access and Assistive Technology (CWUAAT) 2023 invited participants from a wide variety of disciplines to contribute to the discussion on this topic. This book represents the papers presented at this conference, chosen by peer review by an international panel of currently active researchers. The chapters within the book provide a unique insight into current national and international research in the fields of inclusive design, universal access, and assistive and rehabilitative technology. The main sections of the book reflect the following key themes: • Understanding people • Designing for an ageing population • Inclusive built environments • Healthcare • Assistive technology • Design methods • Education and training We hope that this book will be useful to researchers, teachers, students and the general public who are interested in inclusive design and sustainable development.